Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Age-Related Macular Degeneration

16 Aug 2022

Abstract excerpt

Purpose: Age-related macular degeneration (AMD) is the most common cause of aging-related blindness in the developing world. Although medications can slow progressive wet AMD, currently, no drugs to treat dry-AMD are available. We use a systems or in silico biology analysis to identify chemicals and drugs approved by the Food and Drug Administration for other indications that can be used to treat and prevent AMD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Retinal Diseases and Treatments
Share to Retinal Imaging and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35972434
DOI: 10.1167/tvst.11.8.10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using Advanced Bioinformatics Tools to Identify Novel Therapeutic Candidates for Age-Related Macular DegenerationPMID 35972434Read ↗

Integrative genomic and proteomic analyses identify candidate genetic loci and genetically supported proteins in age-related macular degenerationSemantic proximity Read ↗

Integrating Artificial Intelligence and Precision Therapeutics for Advancing the Diagnosis and Treatment of Age-Related Macular DegenerationSemantic proximity Read ↗

Genetics of age-related macular degeneration (AMD).Semantic proximity Read ↗

Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networksSemantic proximity Read ↗

Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.Semantic proximity Read ↗

Multiomic Screening Unravels the Immunometabolic Signatures and Drug Targets of Age-Related Macular DegenerationSemantic proximity Read ↗

Application and interpretation of genome-wide association (GWA) studies for informing pharmacogenomic research - examples from the field of age-related macular degeneration.Semantic proximity Read ↗

A Systematic Review; Efficacy Assessment of Novel Therapy in Treating Age-related Macular DegenerationSemantic proximity Read ↗

Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated DisordersSemantic proximity Read ↗

Repository of proposed pathways and protein–protein interaction networks in age-related macular degenerationSemantic proximity Read ↗

Mechanistic Analysis of Luteolin in Mitigating Dry Age-Related Macular Degeneration through Network Pharmacology and Experimental ValidationSemantic proximity Read ↗

GWAS-based Machine Learning for Prediction of Age-Related Macular Degeneration RiskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.